Brind.
  1. Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement.

Sanofi appointed Paulo Fontoura, who previously served as CMO of Xaira Therapeutics, as Global Head of R&D.

2 reports, 2 independent Updated Jun 27
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Sanofi appointed Paulo Fontoura, who previously served as CMO of Xaira Therapeutics, as Global Head of R&D.

Who's involved

What this event is mainly about
Paulo FontouraHoffmann-La Roche

Keep exploring

Part of

Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped